semaglutide and compounding pharmacies States cracking down on selling knockoff weight-loss drugs Exploring the Ozempic Shortage: Unique

Description

In both the studies, there was a significant increase in heart rate or pulse rate

As of January 2026, 13 states (Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia, and Wisconsin) cover GLP-1 receptor agonists (such as Wegovy) for weight loss

Additionally, GLP-1 signaling influences calcitonin gene-related peptide (CGRP), a neuropeptide strongly implicated in migraine pathophysiologythe same target that newer migraine-specific medications like erenumab address

Ro: Different approaches to weight loss With GLP-1 medications becoming a major part of modern weight management, many people are turning to digital programs for accessible, expert-guided care